264

Bioinformatics of the Brain

Bibliography

[1] M. Downs, J. Zaia, and M. K. Sethi, “Mass spectrometry methods for

analysis of extracellular matrix components in neurological diseases,”

Mass Spectrometry Reviews, vol. 42, no. 5, pp. 1848–1875, 2023.

[2] E. Fingleton, Y. Li, and K. W. Roche, “Advances in proteomics allow

insights into neuronal proteomes,” Frontiers in Molecular Neuroscience,

vol. 14, p. 647451, 2021.

[3] B. C. Carlyle, B. A. Trombetta, and S. E. Arnold, “Proteomic approaches

for the discovery of biofluid biomarkers of neurodegenerative dementias,”

Proteomes, vol. 6, no. 3, p. 32, 2018.

[4] M. D. Filiou, D. Martins-de Souza, P. C. Guest, et al., “To label or not to

label: applications of quantitative proteomics in neuroscience research,”

Proteomics, vol. 12, no. 4-5, pp. 736–747, 2012.

[5] M. G. Sürmen, S. Sürmen, A. Ali, et al., “Phosphoproteomic strategies in

cancer research: a minireview,” Analyst, vol. 145, no. 22, pp. 7125–7149,

2020.

[6] F. Hosp and M. Mann, “A primer on concepts and applications of pro-

teomics in neuroscience,” Neuron, vol. 96, no. 3, pp. 558–571, 2017.

[7] A. Santos, A. R. Colaço, A. B. Nielsen, et al., “A knowledge graph to

interpret clinical proteomics data,” Nature biotechnology, vol. 40, no. 5,

pp. 692–702, 2022.

[8] C. Chen, J. Hou, J. J. Tanner, et al., “Bioinformatics methods for mass

spectrometry-based proteomics data analysis,” International journal of

molecular sciences, vol. 21, no. 8, p. 2873, 2020.

[9] P. Y. Lee, J. Osman, T. Y. Low, et al., “Plasma/serum proteomics: deple-

tion strategies for reducing high-abundance proteins for biomarker dis-

covery,” Bioanalysis, vol. 11, no. 19, pp. 1799–1812, 2019.

[10] P. Bastos, R. Ferreira, B. Manadas, et al., “Insights into the human brain

proteome: disclosing the biological meaning of protein networks in cere-

brospinal fluid,” Critical Reviews in Clinical Laboratory Sciences, vol. 54,

no. 3, pp. 185–204, 2017.

[11] R. Raghunathan, K. Turajane, and L. C. Wong, “Biomarkers in neurode-

generative diseases: Proteomics spotlight on als and parkinson’s disease,”

International Journal of Molecular Sciences, vol. 23, no. 16, p. 9299, 2022.

[12] A. P. Jain and G. Sathe, “Proteomics landscape of alzheimer’s disease,”

Proteomes, vol. 9, no. 1, p. 13, 2021.